Loading clinical trials...
Loading clinical trials...
The Use of SG Diagnostics COVID-19 Antigen Rapid Test Kit for Self-testing as a Method for Reduction SARS-CoV-2
The SG Diagnostics COVID-19 Antigen Rapid Test Kit (Colloidal Gold-Based) is a single-use test kit intended to detect the novel coronavirus SARS-CoV-2 that causes COVID-19. This test is intended for use with self-collected nasal swab samples in individuals who are suspected of COVID-19. This test utilizes a lateral flow immunoassay technology for the qualitative detection of spike and nucleocapsid protein antigens of SARS-CoV-2 in individuals with known or suspected COVID-19.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Maria Sklodowska-Curie Medical Academy
Warsaw, Poland
Start Date
May 11, 2021
Primary Completion Date
June 30, 2021
Completion Date
July 10, 2021
Last Updated
May 17, 2021
200
ESTIMATED participants
SG Diagnostics COVID-19 Antigen Rapid Test Kit
DIAGNOSTIC_TEST
Polymerase chain reaction (PCR) test
DIAGNOSTIC_TEST
Lead Sponsor
Polish Society of Disaster Medicine
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT04896866